About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

About Market Research Forecast

Europe In-vitro Diagnostics Market

Europe In-vitro Diagnostics Market Soars to USD billion , witnessing a CAGR of 7.1 during the forecast period 2025-2033

Europe In-vitro Diagnostics Market by Product Type (Instruments, Reagents & Consumables), by Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology, Others), by Setting (Laboratories, Point of Care), by Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), by End-user (Clinical Laboratories, Hospitals, Physician’s Offices, Others), by Forecast 2026-2034

Jun 17 2025

Base Year: 2025

190 Pages

Europe In-vitro Diagnostics Market Soars to USD billion , witnessing a CAGR of 7.1 during the forecast period 2025-2033

Key Insights

The Europe In-vitro Diagnostics Marketsize was valued at USD 94.67 USD billion in 2023 and is projected to reach USD 153.02 USD billion by 2032, exhibiting a CAGR of 7.1 % during the forecast period.In vitro diagnostics refers to medical exams performed on samples like blood urine or tissues out of doors the frame to diagnose sicknesses infections or conditions those tests encompass diverse technologies inclusive of molecular diagnostics immunoassays clinical chemistry and genetic checking out .IVD performs a pivotal function in healthcare via imparting correct and well timed diagnostic records guiding treatment various check talents and point of care trying out for fast effects . The impact of IVD is profound , improving affected person care thru early disease detection allowing customized medication with genetic and biomarker insights contributing to public fitness surveillance at some stage in outbreaks facilitating clinical research and probably lowering health costs by means of preventing needless remedies IVD is a vital aspect of modern medication improving diagnostics abilties and ultimately reaping benefits affected person effects and healthcare efficiency

Europe In-vitro Diagnostics Trends

Growing prevalence of chronic diseases such as cancer and diabetes.
Rising demand for personalized and precision medicine.
Technological advancements in diagnostic techniques.
Increasing healthcare expenditure in Europe.
Expansion of point-of-care testing.

Europe In-vitro Diagnostics Market Market Size and Forecast (2024-2030) — Europe In-vitro Diagnostics Market Company Market Share

Driving Forces: What's Propelling the Europe In-vitro Diagnostics Market

Enhanced emphasis on preventative healthcare, driven by rising health consciousness and the prevalence of chronic diseases.
Governmental incentives and funding for research and development (R&D) in diagnostics, fostering innovation and technological advancements.
Increased public awareness about the benefits of early disease detection, leading to higher demand for in-vitro diagnostic tests.
Strategic partnerships and collaborations between diagnostic companies, healthcare providers, and research institutions, enhancing market growth through knowledge sharing and resource pooling.

Challenges and Restraints in Europe In-vitro Diagnostics Market

Reimbursement complexities and variations across European countries: Navigating diverse reimbursement policies and securing timely payments for diagnostic tests remains a significant hurdle for market players. This includes challenges related to pricing negotiations and the approval processes for new technologies.
Stringent regulatory landscape and compliance costs: Meeting the rigorous regulatory requirements of the European Union (EU), including those set by the In Vitro Diagnostic Regulation (IVDR), necessitates substantial investments in compliance, potentially hindering smaller companies' growth.
Shortage of skilled professionals and workforce training gaps: A deficiency of trained personnel, particularly in specialized areas like molecular diagnostics and data analysis, can limit the effective utilization of advanced technologies and hamper laboratory operations.
Data privacy and security concerns: The increasing use of digital technologies in diagnostics raises concerns about the protection of patient data, requiring robust cybersecurity measures and compliance with data privacy regulations like GDPR.

Emerging Trends in Europe In-vitro Diagnostics

Artificial intelligence (AI) in diagnostics.
Liquid biopsies.
Multiplex testing.
Telemedicine.

Growth Catalysts in Europe In-vitro Diagnostics Industry

Widespread adoption of advanced technologies: The increasing adoption of next-generation sequencing (NGS), mass spectrometry, and microfluidics is driving innovation and expanding diagnostic capabilities, enabling earlier disease detection and personalized treatment strategies.
Personalized medicine and companion diagnostics: The growing emphasis on personalized medicine is fueling demand for companion diagnostics, which allow for tailoring therapies to individual patient genetic profiles, improving treatment efficacy and reducing adverse effects. This is particularly impactful in oncology and other chronic diseases.
Expansion into high-growth application areas: The market is witnessing robust growth in areas such as precision oncology, pharmacogenomics, infectious disease diagnostics, and rare disease testing, driven by increased research and development efforts and unmet clinical needs.
Technological advancements driving efficiency and affordability: Innovations in automation, point-of-care diagnostics, and remote monitoring are improving the efficiency and accessibility of diagnostic testing, making it more cost-effective and convenient for healthcare providers and patients.
Increasing prevalence of chronic diseases: The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disease is creating a higher demand for diagnostic testing to facilitate early detection, disease monitoring, and treatment optimization.

Market Segmentation: Europe In-vitro Diagnostics Analysis

Product Type:

Instruments
Reagents & Consumables

Technique:

Immunodiagnostics
Clinical Chemistry
Molecular Diagnostics
Hematology
Others

Setting:

Laboratories
Point of Care

Application:

Infectious Diseases
Cardiology
Oncology
Gastroenterology
Others

End-user:

Clinical Laboratories
Hospitals
Physician's Offices
Others

Leading Players in the Europe In-vitro Diagnostics Market

Significant developments in Europe In-vitro Diagnostics Sector

Acquisitions and mergers among market players.
Strategic partnerships for product development and commercialization.
Technological innovations in diagnostic technologies.

Comprehensive Coverage Europe In-vitro Diagnostics Market Report

Detailed market segmentation: In-depth analysis of the market by product type (e.g., clinical chemistry, immunodiagnostics, molecular diagnostics), technique, setting (hospital, laboratory, point-of-care), application, end-user (hospitals, clinics, research institutions), and region.
Comprehensive market dynamics assessment: Thorough evaluation of market drivers, restraints, opportunities, and emerging trends shaping the future of the European in-vitro diagnostics market.
In-depth company profiles: Detailed profiles of key market players, including their product portfolios, market strategies, financial performance, and competitive positioning.
Competitive landscape analysis: A comprehensive analysis of the competitive landscape, including market share analysis, competitive strategies, mergers and acquisitions, and partnerships.
Historical and forecast data: Reliable historical data and accurate forecast data, providing valuable insights into market growth projections and future trends.

Regional Insight

Western Europe: Analysis of major markets including the UK, Germany, France, Italy, and Spain, highlighting their unique market characteristics and growth drivers.
Eastern Europe: Examination of key markets such as Russia, Poland, Czech Republic, Hungary, and Romania, considering factors like economic development and healthcare infrastructure.
Rest of Europe: Coverage of the Nordic countries, Greece, Turkey, and Ireland, highlighting specific market dynamics and growth opportunities.

Europe In-vitro Diagnostics Market Market Share by Region - Global Geographic Distribution — Europe In-vitro Diagnostics Market Regional Market Share

DROCT Analysis

Detailed information on Market Dynamics, Regulations, Opportunities, Competition, and Technology.

Pricing Analysis

Price comparison of various diagnostic tests in different countries.

Import And Export Analysis

Data on import and export volumes and values.

Patent/Trademark Analysis

Information on patents and trademarks related to the European IVD industry.

Geographic Coverage of Europe In-vitro Diagnostics Market

Higher Coverage

Lower Coverage

No Coverage

Europe In-vitro Diagnostics Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 7.1% from 2020-2034
Segmentation	By Product Type Instruments Reagents & Consumables By Technique Immunodiagnostics Clinical Chemistry Molecular Diagnostics Hematology Others By Setting Laboratories Point of Care By Application Infectious Diseases Cardiology Oncology Gastroenterology Others By End-user Clinical Laboratories Hospitals Physician’s Offices Others By Geography

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Growing Prevalence of Allergies to Augment the Demand for Immunotherapy Drugs
- - 3.3. Market Restrains
  - - 3.3.1. Changing Regulatory Environment Creating Operational Barriers May Limit Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. Europe In-vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product Type
  - 5.1.1. Instruments
  - 5.1.2. Reagents & Consumables
- 5.2. Market Analysis, Insights and Forecast - by Technique
  - 5.2.1. Immunodiagnostics
  - 5.2.2. Clinical Chemistry
  - 5.2.3. Molecular Diagnostics
  - 5.2.4. Hematology
  - 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - by Setting
  - 5.3.1. Laboratories
  - 5.3.2. Point of Care
- 5.4. Market Analysis, Insights and Forecast - by Application
  - 5.4.1. Infectious Diseases
  - 5.4.2. Cardiology
  - 5.4.3. Oncology
  - 5.4.4. Gastroenterology
  - 5.4.5. Others
- 5.5. Market Analysis, Insights and Forecast - by End-user
  - 5.5.1. Clinical Laboratories
  - 5.5.2. Hospitals
  - 5.5.3. Physician’s Offices
  - 5.5.4. Others
- 5.6. Market Analysis, Insights and Forecast - by Region
  - 5.6.1.
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 bioMérieux SA (France)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Qiagen N.V. (Germany)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 F. Hoffmann-La Roche Ltd (Switzerland)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 Siemens Healthineers AG (Germany)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 DiaSorin S.p.A. (Italy)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Danaher Corporation (U.S.)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Bio-Rad Laboratories (U.S.)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Abbott (U.S.)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 Becton Dickinson and Company (U.S.)
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)
    - 6.2.10 Quidel Corporation (U.S.)
      6.2.10.1. Overview
      6.2.10.2. Products
      6.2.10.3. SWOT Analysis
      6.2.10.4. Recent Developments
      6.2.10.5. Financials (Based on Availability)

List of Figures

Figure 1: Europe In-vitro Diagnostics Market Revenue Breakdown (USD billion, %) by Product 2025 & 2033
Figure 2: Europe In-vitro Diagnostics Market Share (%) by Company 2025

List of Tables

Table 1: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by Product Type 2020 & 2033
Table 2: Europe In-vitro Diagnostics Market Volume Units Forecast, by Product Type 2020 & 2033
Table 3: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by Technique 2020 & 2033
Table 4: Europe In-vitro Diagnostics Market Volume Units Forecast, by Technique 2020 & 2033
Table 5: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by Setting 2020 & 2033
Table 6: Europe In-vitro Diagnostics Market Volume Units Forecast, by Setting 2020 & 2033
Table 7: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by Application 2020 & 2033
Table 8: Europe In-vitro Diagnostics Market Volume Units Forecast, by Application 2020 & 2033
Table 9: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by End-user 2020 & 2033
Table 10: Europe In-vitro Diagnostics Market Volume Units Forecast, by End-user 2020 & 2033
Table 11: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by Region 2020 & 2033
Table 12: Europe In-vitro Diagnostics Market Volume Units Forecast, by Region 2020 & 2033
Table 13: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by Product Type 2020 & 2033
Table 14: Europe In-vitro Diagnostics Market Volume Units Forecast, by Product Type 2020 & 2033
Table 15: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by Technique 2020 & 2033
Table 16: Europe In-vitro Diagnostics Market Volume Units Forecast, by Technique 2020 & 2033
Table 17: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by Setting 2020 & 2033
Table 18: Europe In-vitro Diagnostics Market Volume Units Forecast, by Setting 2020 & 2033
Table 19: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by Application 2020 & 2033
Table 20: Europe In-vitro Diagnostics Market Volume Units Forecast, by Application 2020 & 2033
Table 21: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by End-user 2020 & 2033
Table 22: Europe In-vitro Diagnostics Market Volume Units Forecast, by End-user 2020 & 2033
Table 23: Europe In-vitro Diagnostics Market Revenue USD billion Forecast, by Country 2020 & 2033
Table 24: Europe In-vitro Diagnostics Market Volume Units Forecast, by Country 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe In-vitro Diagnostics Market?

The projected CAGR is approximately 7.1%.

2. Which companies are prominent players in the Europe In-vitro Diagnostics Market?

Key companies in the market include bioMérieux SA (France), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Danaher Corporation (U.S.), Bio-Rad Laboratories (U.S.), Abbott (U.S.), Becton Dickinson and Company (U.S.), Quidel Corporation (U.S.).

3. What are the main segments of the Europe In-vitro Diagnostics Market?

The market segments include Product Type, Technique, Setting, Application, End-user.

4. Can you provide details about the market size?

The market size is estimated to be USD 94.67 USD billion as of 2022.

5. What are some drivers contributing to market growth?

Growing Prevalence of Allergies to Augment the Demand for Immunotherapy Drugs.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

Changing Regulatory Environment Creating Operational Barriers May Limit Market Growth.

8. Can you provide examples of recent developments in the market?

N/A

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3850, USD 4850, and USD 5850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD billion and volume, measured in Units.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Europe In-vitro Diagnostics Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Europe In-vitro Diagnostics Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the Europe In-vitro Diagnostics Market?

To stay informed about further developments, trends, and reports in the Europe In-vitro Diagnostics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

Middle East & Africa In-vitro Diagnostics Market Future-proof Strategies: Trends, Competitor Dynamics, and Opportunities 2025-2033

U.S. In-vitro Diagnostics Market Future-proof Strategies: Trends, Competitor Dynamics, and Opportunities 2025-2033

Asia Pacific In-vitro Diagnostics Market Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities

In-vitro Diagnostics (IVD) Market 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

In-vitro Diagnostic Services 2025-2033 Overview: Trends, Competitor Dynamics, and Opportunities

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report